Edyta Podsiadly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Edyta Podsiadly has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
S Tylewska-Wierzbanowska
5 shared publicationsS. Tylewska-Wierzbanowska
National Institute of Public Health – National Institute of Hygiene, Warsaw
3 shared publicationsStanisława Tylewska-Wierzbanowska
3 shared publicationsTomasz Chmielewski
National Institute of Hygiene, Warsaw, Poland
3 shared publicationsW Ruzyłło
3 shared publicationsElzbieta Sochon
National Institute of Hygiene, Warsaw, Poland
2 shared publications
Latest Publications
- 1 December 2009
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 15 (s2) , 120-121
Presence of Bartonella spp. in Ixodidae ticks
- 1 December 2009
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 15 (s2) , 120-121
Presence of Bartonella spp. in Ixodidae ticks
- 1 February 2009
- Vol. 26 (152) , 131-5
[Diagnostics of cat scratch disease and present methods of bartonellosis recognition--a case report].
Bartonella infections including cat scratch disease (CSD) is a group of infectious diseases which are diagnosed sporadically. Because of this fact the number of CSD cases in Poland is underestimated and their incidence is markedly lower in comparison to other European countries. The aim of our report is to present various diagnostic methods and possibilities on the basis of two cases with symptoms of CSD. The efficiency of specific Bartonella antibiotic therapy is also discussed.
- 1 February 2009
- Vol. 26 (152) , 131-5
[Diagnostics of cat scratch disease and present methods of bartonellosis recognition--a case report].
Bartonella infections including cat scratch disease (CSD) is a group of infectious diseases which are diagnosed sporadically. Because of this fact the number of CSD cases in Poland is underestimated and their incidence is markedly lower in comparison to other European countries. The aim of our report is to present various diagnostic methods and possibilities on the basis of two cases with symptoms of CSD. The efficiency of specific Bartonella antibiotic therapy is also discussed.
- 27 July 2008
- Published by Wolters Kluwer Health in Transplantation
- Vol. 86 (2S) , 467
CHLAMYDIA PNEUMONIAE INFECTION IN PATIENTS AFTER KIDNEY TRANSPLANTATION TREATED WITH SPIRAMYCIN
- 27 July 2008
- Published by Wolters Kluwer Health in Transplantation
- Vol. 86 (2S) , 467
CHLAMYDIA PNEUMONIAE INFECTION IN PATIENTS AFTER KIDNEY TRANSPLANTATION TREATED WITH SPIRAMYCIN
- 1 June 2007
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 7 (2) , 189-192
Bartonella henselae in Ixodes ricinus Ticks Removed from Dogs
Bartonella spp. is an etiologic agent of vector-borne infections. Bartonella spp. was searched for in adult Ixodes ricinus ticks removed from dogs and cats using specific polymerase chain reaction (PCR) and sequence analysis of gltA gene. Bartonella henselae DNA was detected in 5 of 102 tested ticks. All PCR-positive ticks were removed from dogs. Four of were engorged, one was unfed. The data demonstrate that B. henselae is able to inhabit ticks. This is the first report about the existence of B. henselae in ticks removed from dogs. It is, however, an open issue that needs further investigation if ticks consist a new competent vector involved in transmission of bartonellosis. Vector-Borne Zoonotic Dis. 7, 189–192.
- 1 June 2007
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 7 (2) , 189-192
Bartonella henselae in Ixodes ricinus Ticks Removed from Dogs
Bartonella spp. is an etiologic agent of vector-borne infections. Bartonella spp. was searched for in adult Ixodes ricinus ticks removed from dogs and cats using specific polymerase chain reaction (PCR) and sequence analysis of gltA gene. Bartonella henselae DNA was detected in 5 of 102 tested ticks. All PCR-positive ticks were removed from dogs. Four of were engorged, one was unfed. The data demonstrate that B. henselae is able to inhabit ticks. This is the first report about the existence of B. henselae in ticks removed from dogs. It is, however, an open issue that needs further investigation if ticks consist a new competent vector involved in transmission of bartonellosis. Vector-Borne Zoonotic Dis. 7, 189–192.
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (11-12) , 956-962
Bartonella henselae in the human environment in Poland
The aim of the study was to determine the occurrence of Bartonella henselae reservoir and vectors of infection in the close surroundings of human beings in urban areas of central Poland. The study included mammals (54 dogs, 137 cats) and 102 adult Ixodes ricinus ticks removed from cats and dogs. Blood samples were drawn from each animal and cultured on chocolate agar plates and in mouse fibroblasts L-929 cell line culture. The levels of Bartonella henselae IgG antibodies were determined by indirect immunofluorescence assay. Bartonella spp. strains were isolated from blood of 14 cats (10.2%). Isolates were identified by PCR methods as: B. henselae (18), B. clarridgeiae (1). Blood samples from dogs were consistently negative for Bartonella spp. 59 (45.0%) of 131 tested cats had B. henselae antibodies. B. henselae antibodies were present in 50% of tested dogs, although mostly (96.2%) in low titres ≤1:64. In 4.9% of Ixodes ricinus ticks examined, B. henselae DNA was detected. These data demonstrate that in the urban area of central Poland B. henselae occurs in environmental sources, both in cats and dogs (reservoir) and ticks (possible vector).
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (11-12) , 956-962
Bartonella henselae in the human environment in Poland
The aim of the study was to determine the occurrence of Bartonella henselae reservoir and vectors of infection in the close surroundings of human beings in urban areas of central Poland. The study included mammals (54 dogs, 137 cats) and 102 adult Ixodes ricinus ticks removed from cats and dogs. Blood samples were drawn from each animal and cultured on chocolate agar plates and in mouse fibroblasts L-929 cell line culture. The levels of Bartonella henselae IgG antibodies were determined by indirect immunofluorescence assay. Bartonella spp. strains were isolated from blood of 14 cats (10.2%). Isolates were identified by PCR methods as: B. henselae (18), B. clarridgeiae (1). Blood samples from dogs were consistently negative for Bartonella spp. 59 (45.0%) of 131 tested cats had B. henselae antibodies. B. henselae antibodies were present in 50% of tested dogs, although mostly (96.2%) in low titres ≤1:64. In 4.9% of Ixodes ricinus ticks examined, B. henselae DNA was detected. These data demonstrate that in the urban area of central Poland B. henselae occurs in environmental sources, both in cats and dogs (reservoir) and ticks (possible vector).
- 17 August 2005
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 24 (8) , 507-513
Presence of Chlamydia pneumoniae in patients with and without atherosclerosis
Data published over the past decade show that Chlamydia pneumoniae is likely associated with the development of atherosclerosis. The aim of this study was to ascertain whether C. pneumoniae infections occur more frequently in patients with atherosclerosis than in healthy subjects. A total of 517 persons were studied. Serum samples, leukocytes, and tissue samples were assayed for the presence of C. pneumoniae-specific IgG and IgA antibodies and C. pneumoniae DNA. C. pneumoniae DNA was found in renal, iliac, and brachial vessels, but it was not detected in radial arteries. C. pneumoniae DNA was found most often in directional coronary atherectomy tissue specimens (11/41, 26.8%), but it was also found in the leukocytes of 14.9% (28/188) of patients with atherosclerosis and 24.6% (28/114) of patients without atheroma changes in vessels. Specific IgG and IgA antibodies were present in 63.8 and 49.9% of atheroma patients, respectively. The prevalence of C. pneumoniae antibodies differs significantly in patients with and without atherosclerosis (for IgG, p=0.002, and for IgA, p=0.006). The identification of persons with chlamydial infection of atherosclerotic arteries necessitates the examination of vascular tissues obtained during revascularization procedures. Serological investigation alone cannot identify individuals with vascular chlamydial infections. Detection of C. pneumoniae DNA in peripheral blood mononuclear cells does not seem to be the exclusive marker of persistent vascular infection. A more easily accessible parameter that allows prediction of chlamydial vascular infection is required.
- 17 August 2005
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 24 (8) , 507-513
Presence of Chlamydia pneumoniae in patients with and without atherosclerosis
Data published over the past decade show that Chlamydia pneumoniae is likely associated with the development of atherosclerosis. The aim of this study was to ascertain whether C. pneumoniae infections occur more frequently in patients with atherosclerosis than in healthy subjects. A total of 517 persons were studied. Serum samples, leukocytes, and tissue samples were assayed for the presence of C. pneumoniae-specific IgG and IgA antibodies and C. pneumoniae DNA. C. pneumoniae DNA was found in renal, iliac, and brachial vessels, but it was not detected in radial arteries. C. pneumoniae DNA was found most often in directional coronary atherectomy tissue specimens (11/41, 26.8%), but it was also found in the leukocytes of 14.9% (28/188) of patients with atherosclerosis and 24.6% (28/114) of patients without atheroma changes in vessels. Specific IgG and IgA antibodies were present in 63.8 and 49.9% of atheroma patients, respectively. The prevalence of C. pneumoniae antibodies differs significantly in patients with and without atherosclerosis (for IgG, p=0.002, and for IgA, p=0.006). The identification of persons with chlamydial infection of atherosclerotic arteries necessitates the examination of vascular tissues obtained during revascularization procedures. Serological investigation alone cannot identify individuals with vascular chlamydial infections. Detection of C. pneumoniae DNA in peripheral blood mononuclear cells does not seem to be the exclusive marker of persistent vascular infection. A more easily accessible parameter that allows prediction of chlamydial vascular infection is required.
- 1 January 2005
- Vol. 54 (3) , 215-9
Seroepidemiological studies of Chlamydia pneumoniae infections in 1-36 months old children with respiratory tract infections and other diseases in Poland.
Presence of specific IgM, IgG and IgA antibodies against Chlamydia pneumoniae was evaluated in children aged 1 week to 36 months to investigate the role of C. pneumoniae in respiratory infections and other diseases. Serum samples were obtained from 150 hospitalized children, including 123 children presenting the clinical symptoms of various respiratory tract infections, two children with acute diarrhoea, two children with meningitis, 14 children with urinary tract infection, and 9 children with non-infectious diseases. Levels of specific C. pneumoniae IgM, IgG and IgA serum antibodies were measured by enzyme-linked immunoassay (ELISA). C. pneumoniae IgM antibodies were detected in 16 (13.0 %) of 123 children with respiratory tract infections. Specific IgG antibodies were found in sera of 11 children under 12 months old. Among 27 children without symptoms of a respiratory tract disease, specific C. pneumoniae IgM were found in two (7.4%) children, including one child with meningitis and another child with urinary tract infection. Specific IgA antibodies were not found in any tested child. All cases of C. pneumoniae infections were identified within two calendar years out of eight that were analyzed, i.e. in 1997 and 2000. The incidence of C. pneumoniae infections varied seasonally, with most children infected in autumn. C. pneumoniae IgM antibodies were detected more often in girls (17.9%) then in boys (7.2%). C. pneumoniae infections occur among small children in central Poland. The results of this study indicate that C. pneumoniae may play a role in the etiology of respiratory tract infections in infants and young children.
- 1 January 2005
- Vol. 54 (3) , 215-9
Seroepidemiological studies of Chlamydia pneumoniae infections in 1-36 months old children with respiratory tract infections and other diseases in Poland.
Presence of specific IgM, IgG and IgA antibodies against Chlamydia pneumoniae was evaluated in children aged 1 week to 36 months to investigate the role of C. pneumoniae in respiratory infections and other diseases. Serum samples were obtained from 150 hospitalized children, including 123 children presenting the clinical symptoms of various respiratory tract infections, two children with acute diarrhoea, two children with meningitis, 14 children with urinary tract infection, and 9 children with non-infectious diseases. Levels of specific C. pneumoniae IgM, IgG and IgA serum antibodies were measured by enzyme-linked immunoassay (ELISA). C. pneumoniae IgM antibodies were detected in 16 (13.0 %) of 123 children with respiratory tract infections. Specific IgG antibodies were found in sera of 11 children under 12 months old. Among 27 children without symptoms of a respiratory tract disease, specific C. pneumoniae IgM were found in two (7.4%) children, including one child with meningitis and another child with urinary tract infection. Specific IgA antibodies were not found in any tested child. All cases of C. pneumoniae infections were identified within two calendar years out of eight that were analyzed, i.e. in 1997 and 2000. The incidence of C. pneumoniae infections varied seasonally, with most children infected in autumn. C. pneumoniae IgM antibodies were detected more often in girls (17.9%) then in boys (7.2%). C. pneumoniae infections occur among small children in central Poland. The results of this study indicate that C. pneumoniae may play a role in the etiology of respiratory tract infections in infants and young children.
- 1 June 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 990 (1) , 404-406
Bartonella henselae and Borrelia burgdorferi Infections of the Central Nervous System
Abstract: To investigate the role of B. henselae in patients with symptoms suggesting neuroborreliosis, serum and cerebrospinal fluid samples were tested with serological and PCR methods. Among 17 examined patients, in 12 cases Borrelia burgdorferi infections were detected, in 1 case Bartonella henselae infection was ascertained, and in two patients mixed B. burgdorferi and B. henselae infections were found. These results indicate that mixed infections should be taken into consideration in establishing diagnosis of neurological disorders. Further study of this conclusion is needed.
- 1 June 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 990 (1) , 404-406
Bartonella henselae and Borrelia burgdorferi Infections of the Central Nervous System
Abstract: To investigate the role of B. henselae in patients with symptoms suggesting neuroborreliosis, serum and cerebrospinal fluid samples were tested with serological and PCR methods. Among 17 examined patients, in 12 cases Borrelia burgdorferi infections were detected, in 1 case Bartonella henselae infection was ascertained, and in two patients mixed B. burgdorferi and B. henselae infections were found. These results indicate that mixed infections should be taken into consideration in establishing diagnosis of neurological disorders. Further study of this conclusion is needed.
- 1 June 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 990 (1) , 407-408
Seroprevalence of Bartonella henselae and Bartonella quintana Infections in Poland in 1998–2001
- 1 June 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 990 (1) , 407-408
Seroprevalence of Bartonella henselae and Bartonella quintana Infections in Poland in 1998–2001
- 1 January 2002
- Vol. 56 (3) , 399-407
[Seroprevalence of Bartonella henselae and Bartonella quintana infections in Poland in 1998-2001].
Bartonella henselae and Bartonella quintana infections result in illnesses with symptoms of severity ranging from mild lymphadenopathy (CSD) to systemic disease. The aim of the study was to estimate a prevalence of B. henselae and B. quintana infections in human in Poland. Serum samples collected from 265 patients in 1998-2001 were tested for the presence of antibodies specific to B. henselae and B. quintana. Levels of serum IgM and IgG antibodies to Bartonella henselae and Bartonella quintana were measured with indirect microimmunofluorescence test (MRL Diagnostic, USA). Cats' sera were assessed with indirect microimmunofluorescence test (MRL Diagnostic, USA) and goat immune serum anti-cat IgG FITC conjugate (Sigma, USA). Bartonella henselae specific antibodies were detected in 146 (57.0%) patients with lymphadenopathy. From that number 11.3% have shown specific Bartonella henselae IgM serum antibodies. Bartonella quintana infection was detected with serological methods in 4 patients. It has been found that CSD is a seasonal infection, with most cases occurring in autumn. Most cases of the disease have been recognized in children 8-16 years old. Most of CSD cases (30.1%) were detected in Mazowieckie voivodeship. There were no cases of CSD in Pomorskie, Podkarpackie, Lubuskie and Opolskie voivodeship. The seroprevalence of Bartonella sp. infections in cats was estimated on 86% (31/36). The highest titer of specific Bartonella henselae antibodies detected in cats was 1024. The number of detected Bartonella henselae infections in Poland is very low. It is very probable that the number of cases is underestimated in our country. Cat scratch disease is the most frequently clinically and serologically identified bartonellosis.
- 1 January 2002
- Vol. 56 (3) , 399-407
[Seroprevalence of Bartonella henselae and Bartonella quintana infections in Poland in 1998-2001].
Bartonella henselae and Bartonella quintana infections result in illnesses with symptoms of severity ranging from mild lymphadenopathy (CSD) to systemic disease. The aim of the study was to estimate a prevalence of B. henselae and B. quintana infections in human in Poland. Serum samples collected from 265 patients in 1998-2001 were tested for the presence of antibodies specific to B. henselae and B. quintana. Levels of serum IgM and IgG antibodies to Bartonella henselae and Bartonella quintana were measured with indirect microimmunofluorescence test (MRL Diagnostic, USA). Cats' sera were assessed with indirect microimmunofluorescence test (MRL Diagnostic, USA) and goat immune serum anti-cat IgG FITC conjugate (Sigma, USA). Bartonella henselae specific antibodies were detected in 146 (57.0%) patients with lymphadenopathy. From that number 11.3% have shown specific Bartonella henselae IgM serum antibodies. Bartonella quintana infection was detected with serological methods in 4 patients. It has been found that CSD is a seasonal infection, with most cases occurring in autumn. Most cases of the disease have been recognized in children 8-16 years old. Most of CSD cases (30.1%) were detected in Mazowieckie voivodeship. There were no cases of CSD in Pomorskie, Podkarpackie, Lubuskie and Opolskie voivodeship. The seroprevalence of Bartonella sp. infections in cats was estimated on 86% (31/36). The highest titer of specific Bartonella henselae antibodies detected in cats was 1024. The number of detected Bartonella henselae infections in Poland is very low. It is very probable that the number of cases is underestimated in our country. Cat scratch disease is the most frequently clinically and serologically identified bartonellosis.